Given its role in aging and disease, SIRT1 is a target for therapeutic interventions. SIRT1 activators such as resveratrol and synthetic compounds are being explored for their potential to treat metabolic disorders, neurodegenerative diseases, and even extend lifespan. Clinical trials are ongoing to assess the efficacy and safety of these compounds in humans.
